Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/12/16 → 7/31/23 |
Funding
- Quintiles, Inc. (Prot #GA29145 // Prot #GA29145)
- Genentech, Inc (Prot #GA29145 // Prot #GA29145)
Prot #GA29145: An Open-Label Extension and Safety Monitoring Study of Patients With Moderately to Severely Active Crohn’s Disease Previously Enrolled In The Etrolizumab Phase III Protocol GA29144
- Hanauer, stephen B (PD/PI)
Project: Research project